Cidara Therapeutics, Inc. (CDTX)
220.25
+0.06
(+0.03%)
USD |
NASDAQ |
Dec 12, 12:35
Cidara Therapeutics EPS Diluted (TTM): -11.78 for Sept. 30, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Merck & Co., Inc. | 7.560 |
| Bristol Myers Squibb Co. | 2.962 |
| Johnson & Johnson | 10.36 |
| Mersana Therapeutics, Inc. | -9.433 |
| Pfizer Inc. | 1.716 |